Tomahawk, WI 3/27/2013 (Expedated) – The rest of the week is all down hill from here. Here is a look at some of our volume leaders.

MidweekServiceFacebook (NASDAQ: FB  ) has made a comeback of sorts from the troubles they had shortly after  the launch of the company’s IPO. Today the stock is up almost 4% trading over 44 million shares fo far today with an hour left.

The company has recently been making news as their push to monetize the website’s advertising is picking up steam.

The company has released the following statement on a blog post stating “Allowing advertisers to reach people in News Feed is important because people spend more time in News Feed than any other part of Facebook. We also believe that ads delivered through [Facebook Exchange] will create more relevant ads for people.”

Facebook introduced Exchange, a tool for targeting ads based on browsing history, last fall in hopes of  isplaying more relevant pitches on the right side of the desktop app screen. The new system allows ads to be placed both on the right side and contextually, in Facebook News Feeds.

For now, Facebook says it is conducting a “closed alpha” test with a small number of demand-side advertising platforms, including TellApart, MediaMath, and Nanigans. The company says it plans to bring in additional partners in the coming weeks.

This is a stock we told you about a day or so ago Gilead (Nasdaq:GILD). The stock has traded over twice its daily average today and has hit a new 52-week high. Gilead has a market cap of $68.55 billion and is part of the health care sector and drugs industry.  So far 2013 has been a good year for Gilead as the company’s stock has gone up a little over 24% since the beginning of this year.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia. The company has a P/E ratio of 27.4, above the S&P 500 P/E ratio of 17.7.

Disclaimer: This article is intended for informational and entertainment use only, and should not be construed as professional investment advice. They are my opinions only. Trading stocks is risky — always be sure to know and understand your risk tolerance. You can incur substantial financial losses in any trade or investment. Always do your own due diligence before buying and selling any stock, and/or consult with a licensed financial adviser.


DISCLAIMER: This content is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.